Endovia Health Sciences, Inc. SEC filings EDVA
Endovia Health Sciences, Inc. has 434 filings in SEC EDGAR's recent list, going back to Jul 12, 2012. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 3, 2026 | — |
| EFFECT | Filing | Aug 24, 2026 | — |
| NT 10-Q | Form nt 10-q | Aug 17, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Jun 22, 2026 | — |
| CORRESP | Letter to the SEC | Jun 17, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2026 | — |
| NT 10-Q | Form nt 10-q | May 15, 2026 | Mar 31, 2026 |
| NT 10-K | Form nt 10-k | Apr 1, 2026 | Dec 31, 2025 |
| RW | Form rw | Jan 16, 2026 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| EFFECT | Filing | Dec 22, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| DRS | Filing | Nov 20, 2025 | — |
| NT 10-Q | Form nt 10-q | Nov 17, 2025 | Sep 30, 2025 |
| DRS | Filing | Oct 27, 2025 | — |
| DEFR14A | Form defr14a | Aug 8, 2025 | — |
| 25-NSE | Delisting notice | Aug 5, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2025 | — |
| CORRESP | Letter to the SEC | Jul 28, 2025 | — |
| PRER14A | Form prer14a | Jul 28, 2025 | — |
| D | Filing | Jul 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2025 | — |
| NT 10-Q | Form nt 10-q | May 16, 2025 | Mar 31, 2025 |
| NT 10-K | Form nt 10-k | Apr 1, 2025 | Dec 31, 2024 |
| NT 10-Q | Form nt 10-q | Nov 15, 2024 | Sep 30, 2024 |
| D | Filing | Sep 6, 2024 | — |
| D | Filing | May 14, 2024 | — |
| D | Filing | Oct 31, 2023 | — |
| PRER14A | Form prer14a | Aug 30, 2023 | — |
| NT 10-Q | Form nt 10-q | May 15, 2023 | Mar 31, 2023 |
| EFFECT | Filing | May 1, 2023 | — |
| CORRESP | Letter to the SEC | Apr 27, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2023 | — |
| D | Filing | Jan 13, 2023 | — |
| DEFR14A | Form defr14a | Nov 21, 2022 | — |
| EFFECT | Filing | Oct 8, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2021 | — |
| EFFECT | Filing | Jun 10, 2021 | — |
| CERT | Nyse american certification | Jun 9, 2021 | — |
| 8-A12B | Filing | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 8, 2021 | — |
| CORRESP | Letter to the SEC | Jun 8, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2021 | — |
| D | Filing | Feb 9, 2021 | — |
| D | Filing | Jan 27, 2021 | — |
| RW | Form rw | Sep 30, 2020 | — |
| D | Filing | Sep 2, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2020 | — |
| CORRESP | Letter to the SEC | Jun 5, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2020 | — |
| SC 14F1 | Filing | Mar 31, 2020 | — |
| D | Filing | Jul 9, 2019 | — |
| SC 14F1 | Schedule 14f-1 | Jul 3, 2019 | — |
| NT 10-Q | Notification of late filing | May 14, 2019 | Mar 31, 2019 |
| NT 10-Q | Notification of late filing | Aug 13, 2018 | Jun 30, 2018 |
| NT 10-Q | Notification of late filing | Aug 14, 2017 | Jun 30, 2017 |
| NT 10-Q | Notification of late filing | May 16, 2017 | Mar 31, 2017 |
| D | Filing | Dec 12, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2016 | — |
| NT 10-Q | Canfield medical nt-10q | Nov 14, 2016 | Sep 30, 2016 |
| CORRESP | Letter to the SEC | May 6, 2016 | — |
| CORRESP | Letter to the SEC | May 4, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2016 | — |
| D | Filing | Jan 4, 2016 | — |
| NT 10-K | Canfield medical supply nt-10k 12-31-14 | Mar 31, 2015 | Dec 31, 2014 |
| NT 10-Q | Canfield medical supply 9-30-14 nt 10-q | Nov 13, 2014 | Sep 30, 2014 |
| NT 10-Q | Canfield medical 6-30-14 nt-10q | Aug 14, 2014 | Jun 30, 2014 |
| NT 10-Q | Canfield medical nt-10q 3/31/2014 | May 15, 2014 | Mar 31, 2014 |
| UPLOAD | Letter from the SEC | Apr 4, 2014 | — |
| CORRESP | Letter to the SEC | Apr 2, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2014 | — |
| NT 10-K | Canfield medical nt-10k 12-31-2013 | Mar 28, 2014 | Dec 31, 2013 |
| D | Filing | Mar 13, 2014 | — |
| 8-A12G | Canfield medical form 8-a 12g | Dec 13, 2013 | — |
| NT 10-K | Canfield medical 12b-25 for 12/31/12 10-k | Mar 29, 2013 | Dec 31, 2012 |
| EFFECT | Filing | Feb 12, 2013 | — |
| CORRESP | Letter to the SEC | Feb 8, 2013 | — |
| CORRESP | Letter to the SEC | Feb 4, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2013 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2013 | — |
| CORRESP | Letter to the SEC | Jan 24, 2013 | — |
| CORRESP | Letter to the SEC | Jan 11, 2013 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2013 | — |
| CORRESP | Letter to the SEC | Dec 19, 2012 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2012 | — |
| CORRESP | Letter to the SEC | Nov 9, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2012 | — |
| CORRESP | Letter to the SEC | Oct 2, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2012 | — |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Beverages (SIC 2080)
- Listed as
- EDVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1553788
- Former names
- SPLASH BEVERAGE GROUP, INC. (until Aug 21, 2026); Canfield Medical Supply, Inc. (until Aug 5, 2020)
Other Beverages companies
- Coca Cola Co KO
- Pepsico Inc PEP
- Diageo PLC DEO
- Keurig Dr Pepper Inc. KDP
- Ambev S.A. ABEV
- Constellation Brands, Inc. STZ
- Brown Forman Corp BF-B
- Primo Brands Corp PRMB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.